“type-2-diabetes” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments 05/26/20 San Diego
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome 06/26/19 Boulder/Denver
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing 04/03/19 San Francisco
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later 11/29/18 San Diego
FDA Halts Clinical Test of Zafgen Diabetes Drug, Stock Price Tumbles 11/26/18 Boston
With $59M, Casma and Ex-Constellation CEO Take Aim at Cellular Trash 05/03/18 Boston
Virta Health Hauls in $45M to Expand “Diabetes-Reversing” Software 04/04/18 San Francisco
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More 03/30/18 National
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Novo Nordisk Diabetes Drug Beats Lilly’s Trulicity in Head-to-Head Test 08/17/17 Indiana
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
With Gene Therapy for Diabetes, San Antonio Researcher Eyes Funding 05/31/17 Texas
Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data 05/04/17 Boston
Some See Large EHR Vendors as Playing Catch-up in Population Health 05/03/17 Wisconsin
ViaCyte Working with Gore to Improve its Synthetic Pancreas Device 03/29/17 San Diego
Backed by $37M, Virta Tries Tech Approach to “Reverse” Diabetes 03/08/17 San Francisco
Gates Foundation Sends $140M to Intarcia for HIV Version of Pump 12/29/16 Boston
Diabetes Study, Hiring News, Growth Mileposts, & More Local Tech News 12/27/16 Indiana
Sanofi, Verily Fund Diabetes Startup With $500M 09/12/16 Boston
After Shift to Duchenne and Cholesterol Drugs, Catabasis Files For IPO 05/14/15 Boston
Intarcia, Still Private, Nabs $225M More For Diabetes Device 04/28/15 Boston
Xbiotech’s $76M Offering Sets Course for Late-Stage Cancer Studies 04/15/15 Texas
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill 03/26/15 Boston
Page 1 of 3 next page »